The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
The next hearing on Pfizer's plea is slated for March 21
The 'terrible' surge of the coronavirus cases in India has severely impacted COVAX's vaccine supply in the second quarter of this year to the extent that there will be a shortfall of 190 million doses by the end of June, according to a joint statement by the WHO, UNICEF, GAVI and CEPI.
India has airlifted more than 6 million COVID-19 doses to nine countries in Phase-I under its initiative termed "Vaccine Maitri".
Under the current administration, political attitudes toward IP seem to have improved.
A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains.
'The vaccine policy should be such that all people should get the vaccine free.'
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.
Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.
'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
Gates, who is to attend the World Economic Forum's Annual Meeting, on Monday said there is reason to be optimistic than ever about the future progress using vaccines to give all children a healthy start to life.
The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.
Corporate leaders said a stable government at the Centre will help boost infrastructure spend, address agricultural distress, and encouraging employment.
The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft.
Top companies added employees at 3% CAGR from 2003-04 to 2013-14, while revenues grew at 18%.
What is foreign policy worth if it stands disconnected from domestic realities? Make no mistake, the horrifying visuals of the human suffering in metropolitan India is only the tip of the iceberg. The vast swathes of the hinterland are heaving with untold sorrows, notes Ambassador M K Bhadrakumar.
'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from India.' 'India is showing that in a very competitive environment -- like the US and Europe -- our industry is doing very well.'
Rakesh Jhunjhunwala sounded another note of caution on the nature of the latest bull run.
The tepid economy has hit most sectors, from automobile and pharmaceutical industries in the district to its tourist footfall, reports Archis Mohan
'From the very start, PM Modi was insistent that visiting foreign leaders should be exposed to an India beyond its capital.' 'Through these experiences, he felt that the full Indian narrative would be much better understood across the world,' explains External Affairs Minister S Jaishankar. A riveting excerpt from Bluekraft Digital Foundation's Modi@20: Dreams Meet Delivery.
Kerry is scheduled to head to India later this month for the fourth annual US-India Strategic Dialogue.
Elder Pharmaceuticals has entered into a strategic alliance with UK's Medichem International to develop, manufacture and market advanced medical biosecurity products in India.
The category is expected to cross Rs 38,400 crore by 2020.
The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
WHRL was founded in 1990 by Nobel laureate Sir John Vane to fund the research works at William Harvey Research Institute, one of the leading centres in the world for pharmacological research.
The study claims that from its peak of 18 per cent of gross domestic product in 2008, the crony capitalists' wealth is now down to three per cent
Three IPO documents were recorded after the new govt took charge - Adlabs, Lavasa Corp and Monte Carlo Fashions.
India's tech start-ups are following Silicon Valley's lead and embracing the "fail fast" culture.
India on Thursday secured Mexico's backing in its bid to become member of the Nuclear Suppliers Group as it aggressively scouted for support ahead of a crucial meeting of the 48-nation nuclear trading bloc in Vienna.
Earning woes drag markets lower; TCS, HUL lead fall.
The NITI Aayog's vice-chairman's charge holds ground.
This analysis is based on the quarterly earnings for 724 companies.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances